** Shares of medical device maker Enovis Corp ENOV.N fall 8% to $31.51 premarket
** ENOV cuts its annual profit forecast in the range of $2.95 to $3.10 per share, compared with previous projected range of $3.10 to $3.25
** Co, however, raises its 2025 revenue forecast to be in the range of $2.22 billion to $2.25 billion, compared with prior view of $2.19 billion to $2.22 billion
** "ENOV shares are underperforming on tariff fears," says Brokerage Evercore ISI
** Reports Q1 adjusted profit of 81 cents per share vs estimates of 74 cents - data compiled by LSEG
** Up to last close, stock had fallen ~22% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))